Medicare Enrolled

Dr. Charles Argoff, MD

Neurology · Albany, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
47 NEW SCOTLAND AVE, Albany, NY 12208
5182625226
In practice since 2006 (19 years)
NPI: 1073673125 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Argoff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Argoff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Argoff

Dr. Charles Argoff is a neurology specialist in Albany, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Argoff performed 360 Medicare services across 173 unique beneficiaries.

Between the years covered by Open Payments, Dr. Argoff received a total of $1,332,198 from 57 pharmaceutical and/or device companies across 1368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Argoff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 360 Medicare services $1,332,198 industry payments

Medicare Practice Summary

Medicare Utilization ↗
360
Medicare services
Bottom 44% in NY for neurology
173
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~19 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Spinal drug pump reprogramming and refill
A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir.
205 $30 $184
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
30 $61 $214
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
25 $91 $309
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
23 $68 $359
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $21 $118
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $48 $176
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $70 $271
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $81 $403
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
11 $100 $404
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,332,198
Total received (2018-2024)
Avg $190,314/year across 7 years
Top 0% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$909,782 (68.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$381,108 (28.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$41,308 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$84,853
2023
$163,279
2022
$189,324
2021
$203,081
2020
$180,509
2019
$225,786
2018
$285,366

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$27,079
Tris Pharma Inc
$16,470
VERTEX PHARMACEUTICALS INCORPORATED
$11,958
Averitas Pharma Inc.
$11,158
SCILEX PHARMACEUTICALS INC.
$10,536
Nevro Corp.
$2,750
Lundbeck LLC
$1,474
GlaxoSmithKline, LLC.
$1,300
Shionogi Inc
$915
MML US, Inc.
$308
PFIZER INC.
$221
TerSera Therapeutics LLC
$204
SPR Therapeutics, Inc
$161
Lilly USA, LLC
$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$75
H. Lundbeck A S
$50
Teva Pharmaceuticals USA, Inc.
$20
Tonix Medicines, Inc.
$14
Top 3 companies account for 65.4% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$167,685
Lilly USA, LLC
$152,182
Teva Pharmaceuticals USA, Inc.
$117,315
Daiichi Sankyo Inc.
$97,912
Amgen Inc.
$93,960
AbbVie Inc.
$70,960
ABBVIE INC.
$61,993
Allergan, Inc.
$53,960
Lundbeck LLC
$52,080
GRT US Holding, Inc.
$51,700
Biohaven Pharmaceuticals, Inc.
$39,034
Scilex Pharmaceuticals Inc.
$33,027
VERTEX PHARMACEUTICALS INCORPORATED
$30,382
PFIZER INC.
$26,611
Tris Pharma Inc
$23,194
Kaleo, Inc.
$20,103
Nevro Corp.
$20,100
US WorldMeds, LLC
$19,932
Allergan Inc.
$17,510
Novartis Pharmaceuticals Corporation
$16,476
Biohaven Pharmaceutical Holding Company Ltd.
$16,197
TerSera Therapeutics LLC
$14,489
RedHill Biopharma Inc.
$12,777
GlaxoSmithKline, LLC.
$12,302
IMPEL PHARMACEUTICALS INC.
$11,893
Averitas Pharma Inc.
$11,245
SCILEX PHARMACEUTICALS INC.
$10,536
Jazz Pharmaceuticals Inc.
$10,396
Eli Lilly and Company
$7,826
ARBOR PHARMACEUTICALS, INC.
$7,553
BioDelivery Sciences International, Inc.
$7,489
Kowa Pharmaceuticals America, Inc.
$7,133
Flowonix Medical Incorporated
$6,760
Assertio Therapeutics, Inc.
$5,509
Regeneron Pharmaceuticals, Inc.
$4,918
Ironwood Pharmaceuticals, Inc
$4,753
SK Life Science, Inc.
$3,242
Braeburn Inc.
$2,900
Vertex Pharmaceuticals Incorporated
$2,550
Shionogi Inc
$1,631
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,214
Purdue Pharma L.P.
$971
Pacira Pharmaceuticals Incorporated
$344
MML US, Inc.
$308
Emergent BioSolutions Inc.
$220
Medtronic USA, Inc.
$172
SPR Therapeutics, Inc
$161
Nalu Medical, Inc.
$126
Boston Scientific Corporation
$114
KADMON PHARMACEUTICALS LLC
$108
Abbott Laboratories
$67
H. Lundbeck A S
$50
UROVANT SCIENCES INC
$42
Medtronic, Inc.
$36
AstraZeneca Pharmaceuticals LP
$19
Sumitomo Pharma America, Inc.
$15
Tonix Medicines, Inc.
$14
Top 3 companies account for 32.8% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMYVID · Aimovig · Axium INS DRG IPG · BELBUCA · BOTOX · Belbuca · COMIRNATY · Cenobamate · Dyanavel XR · ELYXYB · ELYXYB - celecoxib · EMGALITY · EVZIO · EXPAREL · Evzio · GEMTESA · GENERAL - PAIN MANAGEMENT · GILENYA · Gralise · Horizant · INTELLIS ADAPTIVESTIM · LUCEMYRA · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · NEURONTIN · NURTEC ODT · Nalu Neurostimulation System · Narcan · Nevro · Nucynta ER · Omnia · PANZYGA · PAXLOVID · PRIALT · Prialt · Prometra II · QULIPTA · QUTENZA · Qutenza · RELISTOR · REYVOW · ReActiv8 · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · Seglentis · Senza · Senza Spinal Cord Stimulation System · Talicia · Trudhesa · UBRELVY · VYEPTI · XTAMPZA · XTAMPZAER · Xtampza · Xtampza ER · XtampzaER · ZEMBRACE SYMTOUCH · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in NY.

Looking for a neurology specialist in Albany?
Compare neurologists in the Albany area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
44
Per 100K population
14.0
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Argoff is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Argoff experienced with spinal drug pump reprogramming and refill?
Based on Medicare claims data, Dr. Argoff performed 205 spinal drug pump reprogramming and refill services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Argoff receive payments from pharmaceutical companies?
Yes. Dr. Argoff received a total of $1,332,198 from 57 companies across 1,368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Argoff's costs compare to other neurologists in Albany?
Dr. Argoff's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Argoff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →